ALDH1A3 and neoplasm: Tumor specimen analysis before treatment in this series confirmed that ALDH1A3 can significantly discriminate pro‐aggressive response in patients, showing not only association but also a linear trend of ALDH1A3 levels to pro‐aggressive response (Fig 7F).